Y-mAbs Therapeutics, Inc.

Report date

6/30/2025

Quarter

2025 Q2

Filed

8/14/2025

2,665

Value ($000)

Weight

0.0%

2019 Q4 - 2025 Q2 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q2	8/14/2025	12	0.0%	2,665	6/30/2025
2025 Q1	5/15/2025	12	0.0%	2,665	3/31/2025
2024 Q4	3/18/2025	231	0.0%	29,481	12/31/2024
2024 Q3	4/4/2025	388	0.0%	29,481	9/30/2024
2024 Q2	4/8/2025	368	0.0%	30,449	6/30/2024
2024 Q1	5/16/2024	60	0.0%	3,700	3/31/2024
2023 Q4	2/13/2024	41	0.0%	6,056	12/31/2023
2023 Q3	11/14/2023	44	0.0%	8,118	9/30/2023
2023 Q2	8/21/2023	83	0.0%	12,238	6/30/2023
2023 Q1	5/9/2023	68	0.0%	13,650	3/31/2023
2022 Q4	2/14/2023	210	0.0%	43,130	12/31/2022
2022 Q3	11/21/2022	616	0.0%	42,704	9/30/2022
2022 Q2	8/15/2022	658	0.0%	43,507	6/30/2022
2022 Q1	5/16/2022	443	0.0%	37,293	3/31/2022
2021 Q4	2/15/2022	667	0.0%	41,126	12/31/2021
2021 Q3	11/15/2021	1,148	0.0%	40,232	9/30/2021
2021 Q2	8/16/2021	1,628	0.0%	48,177	6/30/2021
2021 Q1	5/18/2021	1,391	0.0%	46,008	3/31/2021
2020 Q4	2/16/2021	2,285	0.0%	46,147	12/31/2020
2020 Q3	11/17/2020	1,753	0.0%	45,657	9/30/2020
2020 Q2	8/17/2020	1,950	0.0%	45,144	6/30/2020
2020 Q1	5/13/2020	932	0.0%	35,709	3/31/2020
2019 Q4	2/14/2020	1,129	0.0%	36,112	12/31/2019